Khaitan and CAM act on Embio securing investment from True North
Embio Limited secured an investment from True North, which acquired a minority stake. Khaitan & Co advised Embio across corporate, IP, employment, real estate and litigation due diligence; Cyril Amarchand Mangaldas advised True North across corporate, pharma/healthcare, IP, employment, CCI and real-estate workstreams. Embio manufactures complex high-value APIs and advanced intermediates.
Sources
Open in the live tracker →Related deals
- Morrison Foerster, Khaitan & Co advises Autodesk on acquisition of select tech assets, intellectual property from BIMDeX28 Oct 2026
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Cyril Amarchand Mangaldas advises Triveni Power Transmission on listing of shares post-demerger27 Oct 2026